Catalog No. |
TD-HF998076 |
Species reactivity |
Human |
Applications |
Research Grade Biosimilar |
Host species |
Chimeric |
Isotype |
IgG1-kappa |
Expression system |
Mammalian Cells |
Species |
Human |
Clonality |
Monoclonal |
Target |
T-cell surface antigen T4/Leu-3, T-cell surface glycoprotein CD4, CD4 |
Endotoxin level |
Please contact with the lab for this information. |
Purity |
>95% as determined by SDS-PAGE. |
Purification |
Protein A/G purified from cell culture supernatant. |
Accession |
P01730 |
Form |
Liquid |
Storage buffer |
0.01M PBS, pH 7.4. |
Stability and Storage |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term. |
Alternate Names |
cm-MT412, CAS: 147191-91-1 |
Background |
Priliximab (CEN 000029) is an anti-CD4 humanized monoclonal antibody. Priliximab binds to CD4 on the surface of T cells, resulting in a significant and sustained reduction in circulating CD4+ T cells. Priliximab can be used in research of rheumatoid arthritis (RA). |
Note |
For research use only. Not suitable for clinical or therapeutic use. |